Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 05/22/24 EDT

6.37

-0.18 (-2.75%)

Volume

2,223,525

52 week range

6.35 - 11.46

Open0.00
Day High0.00
Day Low0.00
Prev Close6.37
52 Week High11.46
52 Week High Date04/03/24
52 Week Low6.35
52 Week Low Date05/22/24

Key Stats

Market Cap2.30B
Shares Out360.99M
10 Day Average Volume3.58M
Dividend-
Dividend Yield-
Beta0.81
YTD % Change-20.57

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close6.37
52 Week High11.46
52 Week High Date04/03/24
52 Week Low6.35
52 Week Low Date05/22/24
Market Cap2.30B
Shares Out360.99M
10 Day Average Volume3.58M
Dividend-
Dividend Yield-
Beta0.81
YTD % Change-20.57

RATIOS/PROFITABILITY

EPS (TTM)-1.24
P/E (TTM)-5.12
Fwd P/E (NTM)1.69
EBITDA (TTM)2.937B
ROE (TTM)-441.96%
Revenue (TTM)8.966B
Gross Margin (TTM)70.81%
Net Margin (TTM)-5.34%
Debt To Equity (MRQ)-1,979.73%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Bausch Health Companies Inc

TRADE ALERTWe're exiting a troubled drugmaker and buying 2 stocks with brighter outlooksMay 8, 2024CNBC.com
Jim Cramer's top 10 things to watch in the stock market MondayMay 6, 2024CNBC.com
Cramer: How past mistakes are shaping my thinking on our latest stock gone wrongMay 5, 2024CNBC.com
Earnings will drive the market next week — what we expect from 2 portfolio stocksMay 4, 2024CNBC.com
The market rallied but not our stocks that reported earnings — so we pounced on 2 of themMay 2, 2024CNBC.com

Content From Our Affiliates

Paulson buys Carrols, exits SSR Mining in Q1May 15, 2024TipRanks
Icahn takes stakes in CVR Partners and JetBlue, exits position in FirstEnergyMay 15, 2024TipRanks
Bausch Health Shareholders Approve Key ProposalsMay 15, 2024TipRanks
Bausch Health announces results of 2024 Annual MeetingMay 15, 2024TipRanks
Bausch Health provides update on Norwich litigationMay 14, 2024TipRanks

Profile

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...

John Paulson

Independent Chairman of the Board

Thomas Appio

Chief Executive Officer, Director

John Barresi

Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller

Seana-Lyn Carson

Executive Vice President, General Counsel

Address

2150 Saint-Elzear Blvd W

Laval, QC

H7L 4A8

Canada

https://www.bauschhealth.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BHC Bausch Health Companies Inc	6.37	-0.18	-2.75%
GUD
CPH
HLS
RX Biosyent Inc	9.00	UNCH	UNCH